Nutrien Q1 Earnings Beat Estimates on Record Potash Volumes

08.05.26 16:02 Uhr

Werte in diesem Artikel
Aktien

56,92 EUR -0,38 EUR -0,66%

Indizes

PKT PKT

10.844,1 PKT 81,5 PKT 0,76%

34.937,9 PKT 266,4 PKT 0,77%

Nutrien Ltd. NTR recorded adjusted earnings of 51 cents per share for the first quarter of 2026, up 363.6% year over year. The metric beat the Zacks Consensus Estimate of 48 cents by 6.3%.Sales rose 18.5% year over year to $6,046 million and topped the consensus mark of $5,356.7 million by 12.9%.A key operating highlight was record first-quarter potash sales volumes of 3.51 million tons, supported by strong demand and a well-positioned supply chain.Nutrien Ltd. Price, Consensus and EPS Surprise Nutrien Ltd. price-consensus-eps-surprise-chart | Nutrien Ltd. QuoteNTR's Segment HighlightsNutrien Ag Solutions (Retail) generated first-quarter sales of $3,640 million, up 17.8% from $3,090 million a year ago. Management attributed the increase largely to higher crop nutrient sales volumes from core geographies, supported by an earlier start to field activity in the United States, alongside stronger proprietary product demand. The figure beat our estimate of $3,439 million.The Potash segment posted net sales of $926 million, rising 24.5% year over year on higher global benchmark prices and record sales volumes. The metric beat our estimate of $717 million.Nitrogen net sales increased 14.6% to $1,014 million, primarily reflecting stronger global benchmarks, while volume softness was tied to the absence of production from the Trinidad and New Madrid facilities. The figure beat our estimate of $795 millionPhosphate net sales climbed 34.7% to $485 million, benefiting from higher sales volumes and stronger benchmarks, though results were tempered by higher sulfur input costs. The figure exceeded our estimate of $344 million.NTR's FinancialsNutrien ended the quarter with cash and cash equivalents of $777 million, up from $701 million at the end of 2025. Long-term debt declined 5.6% to $8,825 million from $9,350 million at the end of 2025, while total long-term debt, including the current portion, was $9,861 million compared with $9,863 million at year-end.Cash used in operating activities was $851 million in the first quarter. Nutrien said the year-over-year improvement primarily reflected higher fertilizer benchmark pricing, increased Retail earnings and record potash sales volumes.Nutrien's 2026 OutlookManagement reaffirmed full-year guidance ranges following the quarter. Retail adjusted EBITDA is still expected in the $1.75-$1.95 billion range, reflecting the company’s outlook for crop input demand and downstream execution through the year.Nutrien maintained its sales volume outlook across the upstream portfolio as well. Potash sales volumes are projected at 14.1-14.8 million tons, Nitrogen at 9.2-9.7 million tons and Phosphate at 2.4-2.6 million tons. The company also reiterated capital expenditures guidance of $2-$2.1 billion, with depreciation and amortization expected at $2.4-$2.5 billion and finance costs at $0.65-$0.75 billion.NTR’s Price PerformanceNutrien’s shares have gained 22.9% in the past year compared with the 16.1% rise of the industry.  Image Source: Zacks Investment ResearchNTR’s Zacks Rank & Other Key PicksNTR currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the basic materials space are Idaho Strategic Resources, Inc. IDR, NioCorp Developments Ltd. NB and Hawkins, Inc. HWKN.Idaho is expected to report first-quarter 2026 results on May 14. The Zacks Consensus Estimate for earnings is pegged at 43 cents per share, indicating 258.33% year-over-year growth. IDR sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. NioCorp is expected to report third-quarter fiscal 2026 results on May 14. The consensus estimate for NB’s loss per share is pegged at 2 cents, indicating 83.33% year-over-year growth. NB presently carries a Zacks Rank #1.Hawkins is scheduled to report fiscal fourth-quarter 2026 results on May 13. The Zacks Consensus Estimate for HWKN’s first-quarter earnings per share is pegged at 77 cents. HWKN carries a Zacks Rank #2 (Buy) at present.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Nutrien (Ex Potash Agrium)

Analysen zu Nutrien (Ex Potash Agrium)

DatumRatingAnalyst
10.06.2026Nutrien (Ex Potash Agrium) HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
11.05.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
11.05.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
08.05.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
07.05.2026Nutrien (Ex Potash Agrium) OverweightBarclays Capital
DatumRatingAnalyst
11.05.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
11.05.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
08.05.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
07.05.2026Nutrien (Ex Potash Agrium) OverweightBarclays Capital
07.05.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
DatumRatingAnalyst
10.06.2026Nutrien (Ex Potash Agrium) HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
03.03.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
19.02.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
17.02.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
16.02.2026Nutrien (Ex Potash Agrium) NeutralUBS AG
DatumRatingAnalyst
26.03.2026Nutrien (Ex Potash Agrium) SellUBS AG
18.11.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
09.08.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
23.02.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
07.07.2023Nutrien (Ex Potash Agrium) UnderperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutrien (Ex Potash Agrium) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen